- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Last revisionBoth sides next revision | ||
| home:symptoms:eyes [12.15.2018] – [Medications and eye drops] + prescription drop sallieq | home:symptoms:eyes [12.15.2018] – [Medications and eye drops] sallieq | ||
|---|---|---|---|
| Line 44: | Line 44: | ||
| The MP is designed so that patients can minimize the chance of eye damage due to increased inflammation by maintaining a tight olmesartan blockade. Altering the dose and scheduling of antibiotics will manage the severity of the immunopathology by slowing the rate at which bacteria are destroyed and thus reduce the chance of eye inflammation. In addition, a variety of eye medications and drops are available to treat eye inflammation and dry eye. | The MP is designed so that patients can minimize the chance of eye damage due to increased inflammation by maintaining a tight olmesartan blockade. Altering the dose and scheduling of antibiotics will manage the severity of the immunopathology by slowing the rate at which bacteria are destroyed and thus reduce the chance of eye inflammation. In addition, a variety of eye medications and drops are available to treat eye inflammation and dry eye. | ||
| - | * **Ganfort** – Prescription eye drops lower the pressure in the eye by decreasing the fluid produced and helping the flow of fluid out of the eye chamber. Although GANFORT® PF 0.3/5 eye drops help control your condition, it does not cure it. | + | |
| * **Optive** – Non-prescription eye lubricant, which is a safer option than Restasis. | * **Optive** – Non-prescription eye lubricant, which is a safer option than Restasis. | ||
| * **cyclosporine (Restasis)** – A corticosteroid. Generally contraindicated for MP patients, however, less immunosuppressive than prednisolone. | * **cyclosporine (Restasis)** – A corticosteroid. Generally contraindicated for MP patients, however, less immunosuppressive than prednisolone. | ||
| Line 50: | Line 50: | ||
| * **prednisolone (Prednisone, | * **prednisolone (Prednisone, | ||
| * **terramycin** – An antibacterial eye ointment. | * **terramycin** – An antibacterial eye ointment. | ||
| + | * **Ganfort** – Prescription eye drops which lower the pressure in the eye by decreasing the fluid produced and helping the flow of fluid out of the eye chamber. Although GANFORT® PF 0.3/5 eye drops help control your condition, it does not cure it. | ||
| * **[[home: | * **[[home: | ||
home/symptoms/eyes.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.